Company & Sponsor Intelligence

Norwegian University of Science and Technology

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting1

Completed6

Countries1

Therapeutic footprint

adhdanxietydementia_otherdepressionmigraine_headacheother_psychiatrypain_neuropathy

Indexed studies

NCT01085305The Effectiveness of Parent-Child Interaction Therapy (PCIT)
depression · NorwayNA

NCT01158339Dare to Move: Treatment of Movement Phobia in Patient With Low Back Pain
anxiety · NorwayNA

NCT03301922Metacognitive Therapy and Work Interventions for Patients on Sick Leave Due to Common Mental Disorders
depression · NorwayNA

NCT00247234Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders
other_psychiatry · NorwayNA

NCT03462290Botox Injections for Patients With Persistent Facial Pain
pain_neuropathy · NorwayPHASE2

NCT04010851The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD
adhd · NA

NCT02019017Botox Injection in Treatment of Cluster Headache
migraine_headache · NorwayPHASE1, PHASE2

NCT04541056Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae
dementia_other · NorwayNA

NCT00972634Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer
depression · NorwayCOMPLETED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →